Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
Abstract Immunotherapy with immune checkpoint blockade (ICB) for glioblastoma (GBM) is promising but its clinical efficacy is seriously challenged by the blood-tumor barrier (BTB) and immunosuppressive tumor microenvironment. Here, anti-programmed death-ligand 1 antibodies (aPD-L1) are loaded into a...
Main Authors: | Zhiqi Zhang, Xiaoxuan Xu, Jiawei Du, Xin Chen, Yonger Xue, Jianqiong Zhang, Xue Yang, Xiaoyuan Chen, Jinbing Xie, Shenghong Ju |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-44963-3 |
Similar Items
-
Enhanced Anticancer Activity of 5’-DFUR-PCL-MPEG Polymeric Prodrug Micelles Encapsulating Chemotherapeutic Drugs
by: Alicia J. Sawdon, et al.
Published: (2018-12-01) -
Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells
by: Tang XJ, et al.
Published: (2016-10-01) -
Integrin Targeted Delivery of Chemotherapeutics
by: Kai Chen, Xiaoyuan Chen
Published: (2011-01-01) -
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as
by: Han, Xiaoxing, et al.
Published: (2017) -
Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy
by: Fu Li, et al.
Published: (2019-01-01)